Game Changers 2016: Health Strategies Group

What will be the most game-changing catalyst in industry’s quest to become more patient-oriented?

Two major sets of catalysts are driving all stakeholders in healthcare delivery to become patient-centric. Increased cost sharing and financial accountability are engaging patients in a range of decisions that previously were left to providers. Simultaneously, quality measures that focus on population outcomes are creating awareness of the complex barriers that discourage patient engagement in their healthcare status. The result is the need for providers, insurers, and pharmaceutical stakeholders to engage with patients more holistically to meet the converging goals of outcomes, quality, and satisfaction.

Rod Cavin, managing director

FAST FACTS

Address: East and West Coast Offices

Email: [email protected]

Year Founded: 1992

Employees: 77

Holding Company: N/A

Sample Clients: 100% of the leading biopharmaceutical companies

New Business Contact: Rayna Herman, 949-242-1035

COMPANY PROFILE

Health Strategies Group has been the leader in market access to market research for pharmaceutical and biotech professionals for more than 20 years. We provide a 360-degree view of how all stakeholders fit together to impact market access with custom and syndicated market research.

SERVICES AND OFFERINGS

Health Strategies Group syndicated studies follow a process that starts with asking the right questions of the right respondents using the right methodologies. Our process continues in the hands of experts who deliver results organized to communicate clear and meaningful answers to your questions in the market segments of:

• Brand Access and Distribution Insights

• Company and Account Team Performance and Benchmarking

• Organized Provider Trends and Profiles

• Payer Trends and Profiles

Health Strategies Group Custom Access Insights brings anadvanced set of global market access capabilities, frameworks, and methods, plus our robust panel, to answer your specific market access questions across the product lifecycle, from clinical development to loss of exclusivity.

• Access Landscape, Barriers, and Opportunities

• Account Segmentation

• Product Value Proposition

• Customer Relationships

• Distribution Strategy

• Contracting Strategy

• Patient Access and Reimbursement Support

• Programs and Resources for Market Access Stakeholders

CORE CAPABILITIES

From health plans to IDNs to ACOs, we transform syndicated and custom research results into practical knowledge and strategic recommendations so you can confidently move ahead.

Segments we address:

• Accountable Care Organizations

• Medical Groups

• Integrated Delivery Networks/Health Systems, Hospitals

• Long-term Care

• Employers

• Health Plans

• Insurance Exchanges

• Medicare

• Medicaid

• Pharmacy Benefit Managers

• Specialty Pharmacies/Specialty Distributors